Relapse in Schizophrenia: A Systematic Review of Criteria for Clinical Studies and International Consensus Guidelines to Improve Them [0.03%]
精神分裂症复发：临床研究的标准及国际共识指南的系统评价以改进标准
Oliver D Howes,Bernard R Bukala,Eric Y H Chen et al.
Oliver D Howes et al.
Objective: Relapse prevention is a major goal of schizophrenia treatment. However, there is no standard definition of relapse. To address this, the authors reviewed recent approaches and developed consensus criteria to op...
Reduced Threat-Related Neural Efficiency: A Possible Biomarker for Pediatric Anxiety Disorders [0.03%]
威胁相关的神经效能降低：儿童焦虑障碍的生物标志物候选特征
Julia O Linke,Reut Naim,Simona P Haller et al.
Julia O Linke et al.
Objective: Pediatric anxiety disorders are common and predict adult psychopathology, yet current treatments, such as cognitive-behavioral therapy (CBT), produce lasting remission in less than 50% of affected youths. To su...
Esketamine 5 Years After Approval: Welcome New Data With Continuing Questions [0.03%]
esketamine获批五年后：欢迎新数据，但仍有许多疑问
Alan F Schatzberg,Konstantinos N Fountoulakis
Alan F Schatzberg
Maxwell Zachary Price,Richard Louis Price
Maxwell Zachary Price
Differential Effects of Ovarian Steroids in Women With and Without Premenstrual Dysphoric Disorder: A Replication and Extension of Findings [0.03%]
卵巢激素对经前烦躁障碍患者和无该病女性的影响差异：发现的重复及延伸研究
Shau-Ming Wei,Paul Wakim,Pedro E Martinez et al.
Shau-Ming Wei et al.
Objective: The authors previously demonstrated that symptoms of premenstrual dysphoric disorder (PMDD) remit during ovarian hormone suppression and recur after estradiol or progesterone is reintroduced (addback). In this ...
Esketamine Treatment for Depression in Adults: Response to Price et al. and Canuso et al [0.03%]
氯胺酮治疗成人抑郁症：对Price等和Canuso等的回应
Konstantinos N Fountoulakis,Athanasios Saitis,Alan F Schatzberg
Konstantinos N Fountoulakis
Toward Precision Reproductive Psychiatry: A Call for Targeted, Transdiagnostic Approaches to Premenstrual Disorders [0.03%]
迈向精准生殖精神病学：对经前期障碍靶向和跨诊断方法的呼吁
Tory A Eisenlohr-Moul
Tory A Eisenlohr-Moul
Comment on Esketamine Treatment for Depression in Adults: A PRISMA Systematic Review and Meta-Analysis [0.03%]
成人抑郁症艾司氯胺酮治疗的系统评价和meta分析的评论研究：根据PRISMA声明报告
Carla M Canuso,Cynthia Bossie,Dong-Jing Fu et al.
Carla M Canuso et al.